Loading...

Vitrolife AB (publ)

VTRLYPNK
Healthcare
Medical - Devices
$14.98
$0.00(0.00%)

Vitrolife AB (publ) (VTRLY) Company Profile & Overview

Explore Vitrolife AB (publ)’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Vitrolife AB (publ) (VTRLY) Company Profile & Overview

Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.

SectorHealthcare
IndustryMedical - Devices
CEOBronwyn Brophy O'Connor

Contact Information

46 3 17 21 80 00
Gustaf Werners gata 2, Gothenburg, 421 32

Company Facts

1,150 Employees
IPO DateAug 10, 2016
CountrySE
Actively Trading

Frequently Asked Questions

;